Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin

Contact Dermatitis. 2020 Sep;83(3):237-239. doi: 10.1111/cod.13575. Epub 2020 May 29.

Authors

Liesbeth Gilissen^{1

2}, Sara Huygens², An Goossens^{1

2}, Christine Breynaert^{1

3}, Rik Schrijvers^{1

3}

Affiliations

¹ Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium.
² Department of Dermatology, Contact Allergy Unit, University Hospitals KU Leuven, Leuven, Belgium.
³ Department of Internal Medicine, Allergy and Clinical Immunology, University Hospitals KU Leuven, Leuven, Belgium.

PMID: 32333605
DOI: 10.1111/cod.13575

No abstract available

Keywords: DRESS; acute generalized exanthematous pustulosis; antibiotic; clindamycin; drug eruption; maculopapular exanthema; patch testing.

Publication types

Case Reports

MeSH terms

Acute Generalized Exanthematous Pustulosis / diagnosis
Acute Generalized Exanthematous Pustulosis / etiology
Adult
Aged, 80 and over
Anti-Bacterial Agents / adverse effects*
Clindamycin / adverse effects*
Drug Eruptions / diagnosis*
Drug Eruptions / etiology
Drug Hypersensitivity Syndrome / diagnosis
Drug Hypersensitivity Syndrome / etiology
Female
Humans
Hypersensitivity, Delayed / diagnosis*
Hypersensitivity, Delayed / etiology
Male
Middle Aged
Young Adult

Substances

Anti-Bacterial Agents
Clindamycin

Grants and funding

RS is supported by an FWO senior clinical investigator fellowship 1805518N